Recombinant von Willebrand factor.
作者信息
Schwarz H P, Turecek P L, Pichler L, Mitterer A, Mundt W, Dorner F, Roussi J, Drouet L
机构信息
Immuno AG, Vienna, Austria.
出版信息
Thromb Haemost. 1997 Jul;78(1):571-6.
PMID:9198218
Abstract
摘要
相似文献
1
Recombinant von Willebrand factor.
Thromb Haemost. 1997 Jul;78(1):571-6.
2
Update on the management of von Willebrand disease.
Clin Adv Hematol Oncol. 2008 Jan;6(1):29-30.
3
Molecular basis of von Willebrand disease and its clinical implications.
Haematologica. 2004 Sep;89(9):1036.
4
[Willebrand disease].
Rev Infirm. 2006 Jun-Jul(122):22-4.
5
Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
Acta Haematol. 2009;121(2-3):167-76. doi: 10.1159/000214857. Epub 2009 Jun 8.
6
Prophylaxis in von Willebrand disease.
Ann Hematol. 2007 Oct;86(10):699-704. doi: 10.1007/s00277-007-0343-1. Epub 2007 Jul 19.
7
von Willebrand disease: treatment with or without factor VIII?
J Thromb Haemost. 2007 Jun;5(6):1113-4. doi: 10.1111/j.1538-7836.2007.02560.x.
8
Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease.
Expert Rev Hematol. 2016 Sep;9(9):825-30. doi: 10.1080/17474086.2016.1214070. Epub 2016 Jul 28.
9
Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
Blood Coagul Fibrinolysis. 2009 Mar;20(2):89-100. doi: 10.1097/MBC.0b013e3283254570.
10
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. doi: 10.1177/1076029606296399.
引用本文的文献
1
Porcine and canine von Willebrand factor and von Willebrand disease: hemostasis, thrombosis, and atherosclerosis studies.
Thrombosis. 2010;2010:461238. doi: 10.1155/2010/461238. Epub 2011 Feb 7.
Zotero 插件